We are live on
!
Find out more
CS
Candriam SCA Portfolio holdings
AUM
$19.3B
1-Year Est. Return
39.18%
This Fund
S&P 500
This Quarter
Est. Return
+8.51%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$7.52B
AUM Growth
+$1.2B
(+19%)
Cap. Flow
+$726M
Cap. Flow
% of AUM
9.65%
Top 10 Holdings %
Top 10 Hldgs %
19.11%
Holding
866
New
79
Increased
318
Reduced
279
Closed
56
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amgen
AMGN
|
+$75M |
| 2 |
Biogen
BIIB
|
+$70.7M |
| 3 |
Regeneron Pharmaceuticals
REGN
|
+$60.1M |
| 4 |
Merck
MRK
|
+$54.6M |
| 5 |
Gilead Sciences
GILD
|
+$33.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Advanced Micro Devices
AMD
|
+$19.1M |
| 2 |
IRBT
iRobot
IRBT
|
+$15.5M |
| 3 |
Quest Diagnostics
DGX
|
+$15.4M |
| 4 |
Colgate-Palmolive
CL
|
+$14.8M |
| 5 |
Philip Morris
PM
|
+$12.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 33.26% |
| 2 | Technology | 16.05% |
| 3 | Financials | 11.26% |
| 4 | Consumer Discretionary | 7.98% |
| 5 | Communication Services | 7.66% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
FITB
176
Fifth Third Bancorp
FITB
$52B
| $10.9M | 0.15% |
390,678
+5,835
| +2% | +$171K |
|
177
Heron Therapeutics
HRTX
$86.3M
| $10.8M | 0.14% |
342,400
+273,400
| +396% | +$10.2M |
|
|
CERN
178
DELISTED
Cerner Corp
CERN
| $10.8M | 0.14% |
167,695
-25,870
| -13% | -$1.65M |
|
|
CXO
179
DELISTED
CONCHO RESOURCES INC.
CXO
| $10.6M | 0.14% |
69,655
-13,278
| -16% | -$1.87M |
|
|
CBAY
180
DELISTED
Cymabay Therapeutics
CBAY
| $10.6M | 0.14% |
958,000
+488,000
| +104% | +$6.06M |
|
|
SGEN
181
DELISTED
Seagen Inc. Common Stock
SGEN
| $10.6M | 0.14% |
137,200
+20,600
| +18% | +$1.52M |
|
182
Tesla
TSLA
$1.24T
| $10.6M | 0.14% |
598,485
+5,640
| +1% | +$117K |
|
183
Silicon Laboratories
SLAB
$7.15B
| $10.5M | 0.14% |
113,880
+4,855
| +4% | +$474K |
|
184
Lear
LEA
$7.19B
| $10.4M | 0.14% |
72,057
+26,332
| +58% | +$4.51M |
|
|
MNTA
185
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
| $10.4M | 0.14% |
396,300
-40,200
| -9% | -$1.09M |
|
186
Brookfield
BN
$102B
| $10.3M | 0.14% |
651,467
+167,152
| +35% | +$2.54M |
|
187
Ionis Pharmaceuticals
IONS
$9.35B
| $10.3M | 0.14% |
200,200
+44,400
| +28% | +$2.09M |
|
188
Starbucks
SBUX
$118B
| $10.2M | 0.14% |
180,111
-7,697
| -4% | -$407K |
|
|
HDS
189
DELISTED
HD Supply Holdings, Inc.
HDS
| $10.2M | 0.14% |
238,824
+209,460
| +713% | +$9.18M |
|
|
EVHC
190
DELISTED
Envision Healthcare Holdings Inc
EVHC
| $10.2M | 0.14% |
223,243
+41,895
| +23% | +$1.88M |
|
|
191
Advanced Micro Devices
AMD
$851B
| $10.1M | 0.13% |
327,887
-844,390
| -72% | -$19.1M |
|
192
NVR
NVR
$17.2B
| $10M | 0.13% |
4,054
+1,676
| +70% | +$4.63M |
|
193
Waste Management
WM
$95.9B
| $9.92M | 0.13% |
109,777
-135,158
| -55% | -$12M |
|
194
Arrowhead Research
ARWR
$12.1B
| $9.85M | 0.13% |
+514,000
| New | +$8.44M |
|
195
Canadian Imperial Bank of Commerce
CM
$107B
| $9.82M | 0.13% |
209,838
-7,786
| -4% | -$358K |
|
196
Nutrien
NTR
$32.7B
| $9.77M | 0.13% |
169,252
+126,975
| +300% | +$7.03M |
|
|
HOLI
197
DELISTED
Hollsys Automation Technologies INTERNATIONAL, LTD. COMMON (British Virgin Island)
HOLI
| $9.76M | 0.13% |
456,686
-157,373
| -26% | -$3.43M |
|
198
PG&E
PCG
$47.8B
| $9.65M | 0.13% |
209,831
+51,078
| +32% | +$2.27M |
|
|
BOLD
199
DELISTED
Audentes Therapeutics, Inc
BOLD
| $9.45M | 0.13% |
238,800
+169,300
| +244% | +$6.31M |
|
|
VMW
200
DELISTED
VMware, Inc
VMW
| $9.45M | 0.13% |
60,524
+31,100
| +106% | +$4.76M |
|
Similar funds
PCM
A
MGP
LF
SOMRS
BPA
MIM
Candriam SCA's Q3 2018 Portfolio in Review
As of Q3 2018, Candriam SCA held 866 positions worth $7.52B, up 19% from $6.32B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Candriam SCA deployed $726M of net new capital in Q3 2018, opening 79 new positions and adding to 318 existing holdings. Its largest new stake was Varonis Systems: 541,092 shares worth $13.2M.
By sector, the portfolio is most concentrated in Healthcare at 33% of assets, up from 25% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Advanced Micro Devices, an estimated $19.1M trimmed.
- Candriam SCA's largest Q3 2018 buy was Varonis Systems: 541,092 shares worth $13.2M.
- Candriam SCA added most to Amgen in Q3 2018, an estimated $75M increase.
- Candriam SCA's biggest Q3 2018 reduction was Advanced Micro Devices, cutting an estimated $19.1M.
- Candriam SCA fully exited iRobot in Q3 2018, selling an estimated $15.5M.
- Candriam SCA's ten largest holdings make up 19% of its $7.52B portfolio in Q3 2018.
- Candriam SCA opened 79 new positions and closed 56 in Q3 2018.
- Candriam SCA's portfolio value rose 19% quarter-over-quarter to $7.52B.
Based on Candriam SCA's 13F filing for Q3 2018, filed 7 Nov 2018.